Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-Pentixafor PET/CT for MM and Lymphoma
NCT03436342Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2019
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Peking Union Medical College Hospital. Primary endpoint: Maximum Standardized Uptake Value at 2 years. Status: unknown.
Beyond the preview
Go deeper on NCT03436342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03436342.